Comprehensive 2025 Edible Vaccine Market Overview: Trends, Forecasts, and Growth Drivers

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Edible Vaccine Market Through 2025?
Over the past few years, the edible vaccine market has seen significant growth. It is projected to expand from $8.77 billion in 2024 to $9.6 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The rise in the previous period is a result of advancements in genetic engineering, issues concerning traditional vaccines, developments in biopharming, increased emphasis on worldwide immunization, as well as amplified funding and backing provided by authorities.

What's the Projected Size of the Global Edible Vaccine Market by 2029?
The market size of edible vaccines is anticipated to witness significant expansion in the forthcoming years, with projections suggesting growth to the tune of $13.63 billion in 2029, representing a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period is believed to be driven by factors such as the increased need for pandemic readiness, advancements in the field of plant biotechnology, higher levels of awareness and acceptance of genetically modified foods among the public, the need to address issues related to cold chain, and synchronising with food security programmes. The forecast period also expects trends like reaching out to animal health sectors, escalated usage of biopharming, customised nutrition and vaccination, commitment towards sustainable and eco-friendly vaccines, and the progress in developing multi-antigen edible vaccines.

View the full report here:
https://www.thebusinessresearchcompany.com/report/edible-vaccine-global-market-report

Top Growth Drivers in the Edible Vaccine Industry: What's Accelerating the Market?
The escalating incidences of infectious diseases are anticipated to boost the progression of the edible vaccine market. Illnesses induced by harmful microorganisms like bacteria, viruses, fungi, or parasites, which infiltrate and multiply in the body, are categorized as infectious diseases. The rise in infectious diseases primarily results from factors such as globalization, climate change, urbanization, and resistance to antibiotics, contributing to the spread and appearance of novel pathogens. Genetically modified foods that generate antigens are consumed in edible vaccines to provoke immune responses in infectious diseases, providing an inexpensive and needle-less method of immunization. For example, the Centers for Disease Control and Prevention (CDC), a health agency based in the US, reported in March 2024 that the number of tuberculosis cases had increased by 1,295 from 8,320 in 2022 to 9,615 in 2023. The rate per 100,000 people also rose from 2.5 in 2022 to 2.9 in 2023. Therefore, the escalating prevalence of infectious diseases is a key driver of the growth in the edible vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19040&type=smp

What Trends Will Shape the Edible Vaccine Market Through 2029 and Beyond?
Leading firms in the edible vaccine industry, such as Bharat Biotech International Limited, are investing in innovative strategies like Oral cholera vaccine (OCV) to address the prevalent cholera problem worldwide. The Oral cholera vaccine (OCV), used to prevent the severe diarrheal disease caused by the Vibrio cholerae bacterium, is ingested orally. For instance, the India-based biotechnology company Bharat Biotech International Limited introduced an Oral cholera vaccine named Hillchol in August 2024, which possesses several distinct characteristics. This live-attenuated vaccine triggers both systemic and mucosal immune responses, providing cholera protection. Hillchol is remarkable for its simplicity of use and doesn't need cold storage, making it optimal for use in settings with limited resources. Furthermore, a single dose provides long-lasting immunity.

What Are the Main Segments in the Edible Vaccine Market?
The edible vaccinemarket covered in this report is segmented -

1) By Type: Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Live Attenuated Vaccines, Other Types
2) By Distribution Channel: Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies
3) By Application: Medical Care, Livestock, Aquaculture, Agriculture, Other Applications
4) By End User: Adults, Pediatrics, Animals

Subsegments:
1) By Inactivated Vaccines: Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
2) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
3) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines, Synthetic DNA Vaccines
4) By Live Attenuated Vaccines: Live Attenuated Viral Vaccines, Live Attenuated Bacterial Vaccines
5) By Other Types: Virus-Like Particle (VLP) Vaccines, mRNA Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19040&type=smp

Which Top Companies are Driving Growth in the Edible Vaccine Market?
Major companies operating in the edible vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Santé Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation

Which Regions Will Dominate the Edible Vaccine Market Through 2029?
North America was the largest region in the edible vaccine market in 2024. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19040

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.